Olaparib and Doxorubicin Co-Loaded Polypeptide Nanogel for Enhanced Breast Cancer Therapy.

Front Bioeng Biotechnol · 2022 · PMC9108339 · PMID 35586554

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

As shown in the figure, except for the free drug group, other mice showed lower weight fluctuations under the treatment dose, while the free drug group showed a trend of weight loss.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.